eIF
Eukaryotic gene expression is a process mainly regulated at the levels of gene transcription and mRNA translation. Deregulation of translation (initiation, elongation, termination, recycling) results in abnormal gene expression, and thus leads to uncontrolled cell growth potentially resulting in cancer formation. The major players in canonical translation initiation are the eukaryotic translation initiation factors (eIFs), comprising eIF1, eIF1a, eIF2, eIF2b, eIF3, eIF4a, eIF4e, eIF4g, eIF4b, eIF4h, eIF5 and eIF5b. The canonical process is primed by formation of the 43S preinitiation complex, to which mRNA is recruited together with the eIF4F complex and the poly(A) binding protein (PABP). The 43S pre-initiation complex consists of the small 40S ribosomal subunit, the initiating methionyl-tRNA bound to eIF2-GTP (eIF2-GTP-MettRNAi is also known as the ternary complex) and eIFs 1, 1a and 3. Subsequently, the mRNA is scanned for the first AUG in the 50UTR until correct binding of tRNA anticodon loop to the initiator AUG on the mRNA assisted by eIF1.
The scanning process is facilitated by eIF1 and eIF1a by altering the structure of the mRNA-binding cleft. This interaction enables functional 80S ribosome assembly on the mRNA and translation to take place. eIF3 is believed to function as a scaffold, interacting with other eIFs and the 40S ribosome. The eIF4F complex fulfils a number of tasks in translation initiation, including the scanning process. eIF4e binds to mRNA’s cap structure, eIF4a possesses helicase activity and is suggested to be positioned by eIF4g at the ribosomal mRNA entry channel. An altered translation initiation and therefore changed gene expression is increasing the risk of cancer development. Indeed, previous work showed that dysregulation of many eIFs is associated with malignant transformation and cancer progression.
References
1.Spilka R,et al. Cancer Lett. 2013;340(1):9–21.
The scanning process is facilitated by eIF1 and eIF1a by altering the structure of the mRNA-binding cleft. This interaction enables functional 80S ribosome assembly on the mRNA and translation to take place. eIF3 is believed to function as a scaffold, interacting with other eIFs and the 40S ribosome. The eIF4F complex fulfils a number of tasks in translation initiation, including the scanning process. eIF4e binds to mRNA’s cap structure, eIF4a possesses helicase activity and is suggested to be positioned by eIF4g at the ribosomal mRNA entry channel. An altered translation initiation and therefore changed gene expression is increasing the risk of cancer development. Indeed, previous work showed that dysregulation of many eIFs is associated with malignant transformation and cancer progression.
References
1.Spilka R,et al. Cancer Lett. 2013;340(1):9–21.
Nuclear Receptor/Transcription Factor
eIF
-
Hippuristanol
产品货号 : M16010
cas no: 80442-78-0
Hippuristanol 是一种有效的真核起始因子 4A (eIF4A) 类固醇抑制剂。 -
Elatol
产品货号 : M15006
cas no: 55303-97-4
Elatol (NSC 341593) 是一种体外 eIF4A1 ATP 水解的特异性抑制剂,对多种肿瘤类型具有广泛的活性。 -
4E2RCat
产品货号 : M14472
cas no: 432499-63-3
一种 eIF4E-eIF4G 相互作用的小分子抑制剂,在基于 TR-FRET 的测定中 IC50 为 13.5 uM。 -
4EGI-1
产品货号 : M14029
cas no: 315706-13-9
4EGI-1 是一种竞争性 eIF4E/eIF4G 相互作用抑制剂,Kd 为 25 uM(与 eIF4E 结合)。 -
NH-125
产品货号 : M13851
cas no: 278603-08-0
一种有效的真核 eEF-2 激酶 (eEF2K) 抑制剂,体外 IC50 为 60 nM,可阻断完整细胞中 eEF-2 的磷酸化。